The use of hospital admission data as a measure of outcome in clinical studies of heart failure

被引:39
作者
Metcalfe, C
Thompson, SG
Cowie, MR
Sharples, LD
机构
[1] Inst Publ Hlth, MRC Biostat Unit, Cambridge CB2 2SR, England
[2] Univ London Imperial Coll Sci Technol & Med, Fac Med, Natl Heart & Lung Inst, Dept Cardiac Med, London, England
关键词
heart failure; hospitalization; mortality; disease burden; statistical methods; systematic review;
D O I
10.1016/S0195-668X(02)00384-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim To describe and evaluate the methods currently used to summarize, depict, and analyse hospitalization data in clinical studies of patients with heart failure. Methods and Results Studies published during 1999 and 2000 were reviewed if they reported hospitalization data collected during the follow-up of a defined group of adults who had been diagnosed as having heart failure. Of 130 studies identified, the majority considered only the first of any hospital admissions for each individual. When presented, statistical analyses in 70% of papers, and graphics in 75% of papers, were based purely on the first hospitalization. A minority of papers based analyses on the number of admissions (23%), or the amount of time spent in hospital by patients (14%) during the follow-up period. Conclusions Data on the hospitalizations undergone by patients with heart failure are potentially informative about the disease burden to individuals and health services. The widespread practice of focussing a statistical analysis on the first admission a patient undergoes discards those aspects of hospitalization that are informative about disease burden: multiple admissions and length of stay. Statistical methods that incorporate these aspects appeared in a handful of papers, and the more widespread adoption of these is desirable. (C) 2002 The European Society of Cardiology. Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:105 / 112
页数:8
相关论文
共 12 条
[1]   Hospitalization of patients with heart failure - A population-based study [J].
Cowie, MR ;
Fox, KF ;
Wood, DA ;
Metcalfe, C ;
Thompson, SG ;
Coats, AJS ;
Poole-Wilson, PA ;
Sutton, GC .
EUROPEAN HEART JOURNAL, 2002, 23 (11) :877-885
[2]   The cost-effectiveness of losartan versus captopril in patients with symptomatic heart failure [J].
Dasbach, EJ ;
Rich, MW ;
Segal, R ;
Gerth, WC ;
Carides, GW ;
Cook, JR ;
Murray, JF ;
Snavely, DB ;
Pitt, B .
CARDIOLOGY, 1999, 91 (03) :189-194
[3]  
Davidson A. C., 1997, BOOTSTRAP METHODS TH
[4]   Multi-state models: A review [J].
Hougaard, P .
LIFETIME DATA ANALYSIS, 1999, 5 (03) :239-264
[5]  
LILFORD RJ, 2001, HLTH TECHNOL ASSESS, V5, P7
[6]  
McMurray J, 1993, BR J MED EC, V6, P99
[7]   CONSIDERATIONS IN CHOICE OF A CLINICAL END-POINT FOR AIDS CLINICAL-TRIALS [J].
NEATON, JD ;
WENTWORTH, DN ;
RHAME, F ;
HOGAN, C ;
ABRAMS, DI ;
DEYTON, L .
STATISTICS IN MEDICINE, 1994, 13 (19-20) :2107-2125
[8]   Hospital use and costs among patients with nonischemic cardiomyopathy in the first prospective randomized amlodipine survival evaluation study [J].
O'Connor, CM ;
Radensky, PW ;
Unger, AN ;
Martin, BC .
CLINICAL THERAPEUTICS, 1999, 21 (07) :1254-1265
[9]   Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure [J].
Packer, M .
JOURNAL OF CARDIAC FAILURE, 2001, 7 (02) :176-182
[10]   Prolonged beneficial effects of a home-based intervention on unplanned readmissions and mortality among patients with congestive heart failure [J].
Stewart, S ;
Vandenbroek, AJ ;
Pearson, S ;
Horowitz, JD .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (03) :257-261